WO2000026185A3 - Omeprazole solution and method of using same - Google Patents
Omeprazole solution and method of using same Download PDFInfo
- Publication number
- WO2000026185A3 WO2000026185A3 PCT/US1999/025592 US9925592W WO0026185A3 WO 2000026185 A3 WO2000026185 A3 WO 2000026185A3 US 9925592 W US9925592 W US 9925592W WO 0026185 A3 WO0026185 A3 WO 0026185A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- metal
- group
- proton pump
- pump inhibitor
- bicarbonate salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU19071/00A AU1907100A (en) | 1998-10-30 | 1999-10-29 | Omeprazole solution and method of using same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18342298A | 1998-10-30 | 1998-10-30 | |
US09/183,422 | 1998-10-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000026185A2 WO2000026185A2 (en) | 2000-05-11 |
WO2000026185A3 true WO2000026185A3 (en) | 2000-08-10 |
WO2000026185A9 WO2000026185A9 (en) | 2000-09-21 |
Family
ID=22672726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/025592 WO2000026185A2 (en) | 1998-10-30 | 1999-10-29 | Omeprazole solution and method of using same |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1907100A (en) |
WO (1) | WO2000026185A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6780882B2 (en) | 1996-01-04 | 2004-08-24 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
USRE45198E1 (en) | 1996-01-04 | 2014-10-14 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
MY137726A (en) | 2000-11-22 | 2009-03-31 | Nycomed Gmbh | Freeze-dried pantoprazole preparation and pantoprazole injection |
ES2534713T3 (en) | 2002-10-16 | 2015-04-27 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
TWI337877B (en) * | 2003-07-18 | 2011-03-01 | Santarus Inc | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853230A (en) * | 1986-04-30 | 1989-08-01 | Aktiebolaget Hassle | Pharmaceutical formulations of acid labile substances for oral use |
US5753265A (en) * | 1994-07-08 | 1998-05-19 | Astra Aktiebolag | Multiple unit pharmaceutical preparation |
-
1999
- 1999-10-29 WO PCT/US1999/025592 patent/WO2000026185A2/en active Application Filing
- 1999-10-29 AU AU19071/00A patent/AU1907100A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853230A (en) * | 1986-04-30 | 1989-08-01 | Aktiebolaget Hassle | Pharmaceutical formulations of acid labile substances for oral use |
US5753265A (en) * | 1994-07-08 | 1998-05-19 | Astra Aktiebolag | Multiple unit pharmaceutical preparation |
Non-Patent Citations (2)
Title |
---|
NAKAGAWA ET AL.: "Phase I study of Lansoprazole (AG-1749), anticulcer agent", JOURNAL OF CLINICAL THERAPEUTICS & MEDICINES,, vol. 7, no. 1, January 1991 (1991-01-01), pages 33 - 50, XP002928123 * |
PILBRANT ET AL.: "Development of an oral formulation of omeprazole", SCAND J. GASTROENTEROL.,, vol. 20, (SUPPL. 108), 1985, pages 113 - 120, XP002928124 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6780882B2 (en) | 1996-01-04 | 2004-08-24 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
USRE45198E1 (en) | 1996-01-04 | 2014-10-14 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
Also Published As
Publication number | Publication date |
---|---|
WO2000026185A2 (en) | 2000-05-11 |
WO2000026185A9 (en) | 2000-09-21 |
AU1907100A (en) | 2000-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4778810A (en) | Nasal delivery of caffeine | |
IS1694B (en) | Medicinal product for administration to oral animals containing proton pump blockers | |
IE871981L (en) | Programmed release formulation. | |
TW359614B (en) | Composition containing benzimidazole compounds for rectal administration | |
WO2002019999A3 (en) | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant | |
WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
CA2336945A1 (en) | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate | |
WO2001041742A3 (en) | Antiviral medication | |
NZ514129A (en) | Tolperison-containing, pharmaceutical preparation for oral administration | |
UA66812C2 (en) | Drug formulation with controlled release of active ingredient | |
CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
WO2000026185A3 (en) | Omeprazole solution and method of using same | |
MY129946A (en) | Compound with gastric acid inhibitory effect and process for its preparation. | |
NO950134L (en) | Formulations for orally administered pharmaceutical agents | |
WO2000048445A3 (en) | Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence | |
AU4898890A (en) | A system for the controlled release of active agents and a process for its preparation | |
WO1991018606A3 (en) | Orally active nonaddicting analgesics | |
WO2000048582A3 (en) | Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence | |
ATE212550T1 (en) | MEDICINAL PREPARATIONS CONTAINING TIAGABINE WITH CONTROLLED ADMINISTRATION OF ACTIVE INGREDIENTS | |
AU2907800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism | |
WO2002053097A3 (en) | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination | |
AU2001258859A1 (en) | Pralmorelin-containing nasal drop preparations | |
WO2004050019A3 (en) | Method and compositions for treating anxiety | |
RU2003106417A (en) | APPLICATION OF A VITAMIN COMBINATION FOR TREATMENT OF PRIMARY HEAD PAIN | |
WO2001041771A3 (en) | Transdermal system containing acetylsalicylic acid for treatment of migraine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 45, 47 AND 48, DESCRIPTION, REPLACED BY NEW PAGES 45, 47 AND 48; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |